Ledger.Open graph →
SEC Form D · filed December 31, 2012

Ultragenyx Pharmaceutical Inc

Offering
$75.0M
Sold
$75.0M
Exemption
—
Industry
Biotechnology
Location
NOVATO, CA
Type
—

People & firms on this filing (13)

Shalini Sharp · New York, NYExecBen Auspitz · Bozeman, MTDirectorEmil D. Kakkis · NOVATO, CAExec · DirectorThomas Kassberg · NOVATO, CAExecShalini Sharp · DURHAM, NCExecSteven Jungles · NOVATO, CAExecJohn Ditton · Novato, CAExecCordelia Leonard · NOVATO, CAExecVimal Srivastava · NOVATO, CAExecEran Nadav · Sandy Hook, CTDirectorBen Auspitz · DURHAM, NCDirectorMarten Steen · NOVATO, CADirectorWilliam Aliski · Novato, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗